Literature DB >> 16950407

Cytochrome P450 1A isoenzymes in brain cells: Expression and inducibility in cultured rat brain neuronal and glial cells.

Nidhi Kapoor1, Aditya B Pant, Alok Dhawan, Uppendra N Dwievedi, Prahlad K Seth, Devendra Parmar.   

Abstract

Studies initiated to determine the expression of CYP1A1/1A2 isoenzymes in the primary cultures of rat brain neuronal and glial cells revealed significant activity of CYP1A-dependent 7-ethoxyresorufin-o-dealkylase (EROD) in microsomes prepared from both rat brain neuronal and glial cells. RT-PCR and immunocytochemical studies demonstrated constitutive mRNA and protein expression of CYP1A1 and 1A2 isoenzymes in cultured neuronal and glial cells. Cultured neurons exhibited relatively higher constitutive mRNA and protein expression of CYP1A1 and 1A2 isoenzymes, associated with higher activity of EROD than the glial cells. Induction studies with 3-methylchlorantherene (MC), a known CYP1A-inducer, resulted in significant concentration dependent increase in the activity of EROD in cultured rat brain cells with glial cells exhibiting a greater magnitude of induction than the neuronal cells. This difference in the increase in enzyme activity was also observed with RT-PCR and immunocytochemical studies, indicating relatively higher increase in CYP1A1 and 1A2 mRNA as well as protein expression in the cultured glial cells when compared to the neuronal cells. The greater magnitude of induction of CYP1A1 in glial cells is of significance, as these cells are components of the blood-brain barrier and it is suggested that they have a potential role in the toxication-detoxication mechanism. Our data indicating differences in the expression and sensitivity of CYP1A1 isoenzymes in cultured rat brain cells will not only help in identifying and distinguishing xenobiotic metabolizing capability of these cells but also in understanding the vulnerability of these specific cell types towards neurotoxicants.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16950407     DOI: 10.1016/j.lfs.2006.08.002

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

Review 1.  An Overview on Human Umbilical Cord Blood Stem Cell-Based Alternative In Vitro Models for Developmental Neurotoxicity Assessment.

Authors:  Abhishek Kumar Singh; Mahendra Pratap Kashyap
Journal:  Mol Neurobiol       Date:  2015-06-04       Impact factor: 5.590

2.  3-methylcholanthrene induces neurotoxicity in developing neurons derived from human CD34+Thy1+ stem cells by activation of aryl hydrocarbon receptor.

Authors:  Abhishek K Singh; Mahendra P Kashyap; Vivek Kumar; Vinay K Tripathi; Dharmendra K Yadav; Firoz Khan; Sadaf Jahan; Vinay K Khanna; Sanjay Yadav; Aditya B Pant
Journal:  Neuromolecular Med       Date:  2013-07-12       Impact factor: 3.843

3.  Melatonin metabolism in the central nervous system.

Authors:  Rüdiger Hardeland
Journal:  Curr Neuropharmacol       Date:  2010-09       Impact factor: 7.363

Review 4.  Taxon- and Site-Specific Melatonin Catabolism.

Authors:  Rüdiger Hardeland
Journal:  Molecules       Date:  2017-11-21       Impact factor: 4.411

Review 5.  The role of efflux transporters and metabolizing enzymes in brain and peripheral organs to explain drug-resistant epilepsy.

Authors:  Marta Vázquez; Pietro Fagiolino
Journal:  Epilepsia Open       Date:  2021-10-01

6.  Differences in the expression and sensitivity of cultured rat brain neuronal and glial cells toward the monocrotophos.

Authors:  Vinay Kumar Tripathi; Vivek Kumar; Abhishek Kumar Singh; Mahendra Pratap Kashyap; Sadaf Jahan; Dipak Kumar; Mohtashim Lohani
Journal:  Toxicol Int       Date:  2013-05

7.  Monocrotophos induces the expression and activity of xenobiotic metabolizing enzymes in pre-sensitized cultured human brain cells.

Authors:  Vinay K Tripathi; Vivek Kumar; Abhishek K Singh; Mahendra P Kashyap; Sadaf Jahan; Ankita Pandey; Sarfaraz Alam; Feroz Khan; Vinay K Khanna; Sanjay Yadav; Mohtshim Lohani; Aditya B Pant
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.